It is speculated that age-related decreases in growth hormone and insulin-like growth factor-1 concentrations[25] may influence NMES-related inhibition of muscle atrophy in older patients; however, the factors are unclear, as differences in muscle protein catabolism and responsiveness to NMES in different age groups of older patients are not known. This evidence concerns the gene IGF1 and muscle atrophy.